Key evidence points: GLP-1 medications do not directly target or break down muscle tissue Lean mass loss occurs as a consequence of the calorie deficit and weight reduction The proportion of lean mass lost is comparable to other weight loss methods Greater absolute lean mass loss reflects the greater total weight loss achieved Regulatory bodies including NICE and the MHRA have not identified muscle loss as a specific adverse effect requiring special warnings in the Summary of Product Characteristics (SmPCs), though healthcare professionals are advised to monitor nutritional status and encourage appropriate dietary protein intake and physical activity in patients using these medications for weight management
however, testosterone has also been shown to regulate a multitude of ergogenic, anabolic, and anti-catabolic functions in skeletal muscle, without prior conversion to DHT (Bhasin et al., 2009), leading to increased muscle strength, power, endurance, and hypertrophy in a dose-dependent manner (Sinha-Hikim et al., 2006
Cautions and Significant Reflections Always take prescribed dose of Ozempic
When reviewing the database with NAD + precursors as interventions yet with the other term input using aging , it indicates that there are currently no ongoing or published clinical trials for NA, 2 trials exploring NAM, 4 trials examining NAD + , 5 trials investigating NMN, and 18 trials focused on NR in elderly cohorts
This biological rebound typically occurs 612 months into treatment and creates the illusion that semaglutide has stopped working
